You are here: Industry Insights > Sanofi

News List

Sanofi walks away from Voyager’s phase 2/3 Parkinson’s gene therapy biospectrumasia
November 02, 2017
Under Voyager’s Collaboration Agreement with Sanofi Genzyme, Sanofi Genzyme had an exclusive option for ex-U.S. development and commercial rights to VY-AADC
Sanofi unveils new signature expressbpd
October 20, 2017
Sanofi’s has unveiled its new Signature ‘Empowering Life’. ‘Empowering Life’ represents, in two powerful words, our ambition to support millions of people facing big and small health challenges, whether they be lifelong or temporary.
Sanofi plans summit to tackle diabetes in 5 million Nigerian citizens pharmafile
October 18, 2017
Sanofi Aventis Nigeria plans to put together a National Diabetes Summit to address crisis in the country as five million of the nation’s citizens currently live with the condition.
New trial ordered, all previous judgements vacated in Sanofi, Amgen Praluent® (alirocumab) patent ca pharmaasia
October 18, 2017
Sanofi and Regeneron will continue all regular Praluent® (alirocumab) sales and operations in the U.S. as usual in the meantime.
Aimmune Therapeutics to collaborate with Sanofi/Regeneron biospectrumasia
October 18, 2017
The three companies are planning a 2018 midstage test of AR101 with adjunctive dupilumab in peanut-allergic patients
Sanofi India celebrates ‘DaanUtsav’ expressbpd
October 17, 2017
The company’s CSR team organised a series of activities where every employee was asked to spend four hours with children from vulnerable sections of society
Sanofi Invests €170M in New Vaccine Facility in France contractpharma
October 16, 2017
Will allow Sanofi Pasteur to expand the global supply of its new quadrivalent influenza vaccine VaxigripTetra
EC grants marketing authorisation for Sanofi and Regeneron’s Dupixent for AD pharmaceufical-technology
September 30, 2017
Approved for AD patients who are candidates for systemic therapy, Dupixent is the first targeted biologic in the European Union to receive authorisation for the chronic inflammatory disease.
Sanofi and Regeneron’s projected blockbuster gains EU approval pharmafile
September 29, 2017
Sanofi and Regeneron have big hopes for their treatment Dupixent, and it has taken an important step towards reaching the blockbuster sales pinned to it with an approval in the EU.
Sanofi's arthritis treatment Kevzara secures NICE recommendation pharmafile
September 26, 2017
Sanofi, along with its speciality care global business unit Sanofi Genzyme, are celebrating the news that NICE has passed its final appraisal determination on the company’s Kevzara (sarilumab)

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page